Αποτελέσματα Αναζήτησης
Asymptomatic endometrial polyps in postmenopausal women should be removed in case of large diameter (> 2 cm) or in patients with risk factors for endometrial carcinoma (level B).
- Endometrial polyps: Pathogenesis, sequelae and treatment
Endometrial polyps are mostly asymptomatic lesions, although...
- Endometrial Polyp - StatPearls - NCBI Bookshelf
The prevalence of malignant endometrial polyps in...
- Endometrial polyps: Pathogenesis, sequelae and treatment
11 Οκτ 2023 · Endometrial polyps are common after menopause and in people who have not yet gone through menopause. The malignancy rates are small in both groups but vary by menopausal status.
1 Μαΐ 2021 · Postmenopausal women with vaginal bleeding and suspected endometrial polyp should be offered diagnostic hysteroscopy with hysteroscopic polypectomy if endometrial polyps are present (level B).
Endometrial polyps are mostly asymptomatic lesions, although they can present with abnormal uterine bleeding. 46 Abnormal uterine bleeding is the most common symptom of endometrial polyps, occurring in approximately 68% of both pre- and postmenopausal women with the condition. 47 The bleeding may be due to stromal congestion within the polyp ...
8 Φεβ 2024 · Endometrial polyps are one of the most common etiologies of abnormal genital tract bleeding in both premenopausal and postmenopausal patients (table 1). Unlike polyps of other etiologies (eg, colon), the vast majority of endometrial polyps are neither malignant nor premalignant.
5 Φεβ 2024 · Endometrial polyps are a common diagnosis in both pre- and postmenopausal patients (high). 2. Patients with endometrial polyps may present with abnormal uterine bleeding, postmenopausal bleeding, infertility, or may be asymptomatic (high). 3.
25 Απρ 2023 · The prevalence of malignant endometrial polyps in symptomatic postmenopausal females is 4.47% compared with 1.51% in an asymptomatic postmenopausal female. Additional risk factors for malignant endometrial polyps include age greater than 60, large-sized polyps, menopause status, symptomatic bleeding, and polycystic ovarian syndrome.
